Evaluation of the acute and sub-acute toxicity of the standardized extract of Avicennia officinalis L. in mice

Abstract

Avicennia officinalis L. (AOL) has shown promise for its anti-inflammatory, anti-cancer, and antioxidant properties. However, there is no research on the toxicity of this plant in Vietnam. The acute and sub-acute toxicology study proved that AOL leaf extracts are practically non-toxic in normal mice. Acute toxicity assessment was conducted with single oral doses of AOL extract (2500, 3100, 4100, and 5000 mg/kg). In sub-acute toxicity, mice were administered daily oral doses of AOL extract (200 and 400 mg/kg) for 28 days. Blood was collected from the heart, liver, and kidneys for further analysis. The comprehensive results revealed an oral median lethal dose (LD50) exceeding 5000 mg/kg, indicating low acute toxicity. A sub-acute study (200 and 400 mg/kg/day) showed no deaths or weight gain. At both doses, the standardized AOL extracts decreased serum aspartate transaminase activity. Administration of the 200 mg/kg group significantly increased blood urea levels; however, histological examination of mouse kidneys in this group revealed no signal of damage. Histological examination of mouse livers revealed mild degeneration, possibly due to the use of adult mice and potentially unrelated to the extract. This study emphasizes AOL's potential for further pharmacological testing based on its low acute toxicity and promising results.